Chemomab Therapeutics Ltd. (CMMB) › Net IncomeChemomab Therapeutics Ltd. (CMMB) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$13.80M2019: -$27.12M2020: -$5.95M2021: -$12.48M2022: -$27.65M2023: -$24.22M2024: -$13.95M2025: -$8.99M-$8.99M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$8.99M+35.5%2024-$13.95M+42.4%2023-$24.22M+12.4%2022-$27.65M-121.6%2021-$12.48M-109.7%2020-$5.95M+78.1%2019-$27.12M-96.6%2018-$13.80M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share